Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Vasomune Therapeutics Inc.
DescriptionSynthetic angiopoietin 1 (ANG1; ANGPT1) mimetic that agonizes tyrosine kinase receptor 2 (Tie2)
Molecular Target Tyrosine kinase receptor 2 (Tie2)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationRenal damage
Indication DetailsTreat acute kidney injury (AKI)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today